ETF Home ETF List Shorted Stocks Home About

Portfolio Holdings Detail for ISIN IE00BYXG2H39
Stock Name / FundiShares Nasdaq US Biotechnology UCITS ETF USD (Acc)
IssuerBlackrock
Entity holding fund iShares IV Public Limited Company
Entity TypeUmbrella investment company with variable capital and having segregated liability between its funds
Entity LEI 549300ZP07LMR36K1T02
ETF TickerBTEC(USD) LSE
ETF TickerBTEK(GBP) LSE
ETF Ticker2B70(EUR) F
ETF Ticker2B70.DE(EUR) CXE
ETF TickerBTEC.LS(USD) CXE
ETF TickerBTEK.LS(GBP) CXE
ETF TickerBTEC.L(GBP) LSE
ETF TickerBTEK.L(GBP) LSE

Holdings detail for PYXS

Stock NamePyxis Oncology Inc
TickerPYXS(USD) NASDAQ
TYPECommon Stock
CountryUSA
ISINUS7473241013

Show aggregate PYXS holdings

News associated with PYXS

Zacks Research Upgrades Pyxis Oncology (NASDAQ:PYXS) to “Hold”
Zacks Research upgraded shares of Pyxis Oncology (NASDAQ:PYXS – Free Report) from a strong sell rating to a hold rating in a research report released on Monday,Zacks.com reports. Separately, HC Wainwright reiterated a “buy” rating and issued a $5.00 price target on shares of Pyxis Oncology in a research note on Tuesday. Three analysts have […] - 2025-08-21 02:58:50
Analysts Set Pyxis Oncology, Inc. (NASDAQ:PYXS) Price Target at $9.00
Shares of Pyxis Oncology, Inc. (NASDAQ:PYXS – Get Free Report) have received a consensus recommendation of “Moderate Buy” from the five analysts that are presently covering the company, Marketbeat Ratings reports. One equities research analyst has rated the stock with a hold rating and four have given a buy rating to the company. The average […] - 2025-08-08 03:00:50
Pyxis Oncology, Inc. (NASDAQ:PYXS) Receives Average Rating of “Moderate Buy” from Analysts
Pyxis Oncology, Inc. (NASDAQ:PYXS – Get Free Report) has been assigned an average recommendation of “Moderate Buy” from the five brokerages that are presently covering the stock, MarketBeat.com reports. One equities research analyst has rated the stock with a hold rating and four have assigned a buy rating to the company. The average 1 year […] - 2025-07-11 05:23:04
Pyxis Oncology (NASDAQ:PYXS) Stock Price Up 3.6% – Time to Buy?
Pyxis Oncology, Inc. (NASDAQ:PYXS – Get Free Report) shares rose 3.6% during trading on Monday . The stock traded as high as $1.16 and last traded at $1.14. Approximately 617,104 shares changed hands during mid-day trading, a decline of 16% from the average daily volume of 734,339 shares. The stock had previously closed at $1.10. […] - 2025-07-08 04:35:06
Brokerages Set Pyxis Oncology, Inc. (NASDAQ:PYXS) PT at $9.00
Shares of Pyxis Oncology, Inc. (NASDAQ:PYXS – Get Free Report) have earned a consensus rating of “Moderate Buy” from the five analysts that are presently covering the company, MarketBeat.com reports. One research analyst has rated the stock with a hold rating and four have issued a buy rating on the company. The average 12-month price […] - 2025-06-19 02:14:53
Deutsche Bank AG Cuts Stake in Pyxis Oncology, Inc. (NASDAQ:PYXS)
Deutsche Bank AG lowered its position in shares of Pyxis Oncology, Inc. (NASDAQ:PYXS – Free Report) by 87.3% in the fourth quarter, Holdings Channel reports. The institutional investor owned 30,300 shares of the company’s stock after selling 208,090 shares during the period. Deutsche Bank AG’s holdings in Pyxis Oncology were worth $47,000 as of its […] - 2025-06-05 04:32:50
Millennium Management LLC Purchases 1,043,228 Shares of Pyxis Oncology, Inc. (NASDAQ:PYXS)
Millennium Management LLC grew its position in shares of Pyxis Oncology, Inc. (NASDAQ:PYXS – Free Report) by 53.8% in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 2,980,906 shares of the company’s stock after acquiring an additional 1,043,228 shares […] - 2025-05-29 04:52:57
Pyxis Oncology, Inc. (NASDAQ:PYXS) Given Consensus Rating of “Moderate Buy” by Analysts
Pyxis Oncology, Inc. (NASDAQ:PYXS – Get Free Report) has received an average recommendation of “Moderate Buy” from the five analysts that are covering the firm, MarketBeat reports. One investment analyst has rated the stock with a hold recommendation and four have given a buy recommendation to the company. The average twelve-month price objective among brokers […] - 2025-05-27 04:49:00
HC Wainwright Reiterates Buy Rating for Pyxis Oncology (NASDAQ:PYXS)
Pyxis Oncology (NASDAQ:PYXS – Get Free Report)‘s stock had its “buy” rating reaffirmed by equities researchers at HC Wainwright in a research note issued on Monday,Benzinga reports. They currently have a $5.00 price target on the stock. HC Wainwright’s target price would suggest a potential upside of 313.22% from the company’s previous close. HC Wainwright […] - 2025-05-21 03:03:18
Graham Capital Management L.P. Purchases New Shares in Pyxis Oncology, Inc. (NASDAQ:PYXS)
Graham Capital Management L.P. purchased a new stake in Pyxis Oncology, Inc. (NASDAQ:PYXS – Free Report) in the fourth quarter, Holdings Channel.com reports. The fund purchased 30,287 shares of the company’s stock, valued at approximately $47,000. A number of other institutional investors and hedge funds have also bought and sold shares of the stock. Caption […] - 2025-05-20 05:41:02

iShares Nasdaq US Biotechnology UCITS ETF USD (Acc) PYXS holdings

DateNumber of PYXS Shares HeldBase Market Value of PYXS SharesLocal Market Value of PYXS SharesChange in PYXS Shares HeldChange in PYXS Base ValueCurrent Price per PYXS Share HeldPrevious Price per PYXS Share Held
Share price and value of shares held is calculated on the adjusted close price of each day (row). Changes between days reflect the gain/loss of the portfolio as a result of changes in the adjusted close price and changes in the holdings

Share Trades of PYXS by Blackrock for IE00BYXG2H39

Show aggregate share trades of PYXS

DateActionQuantityMarket HighMarket LowLikely Trade PriceLikely Trade Value (Profit/Loss)Average Price previous trades
2025-10-06BUY2912.4702.650 2.632USD 766 1.30
2025-10-03BUY6792.5702.580 2.579USD 1,751 1.29
2025-10-02BUY972.2502.280 2.277USD 221 1.29
2025-09-30BUY1942.2202.273 2.268USD 440 1.28
2025-09-26BUY1942.1402.170 2.167USD 420 1.27
2025-09-25BUY1942.0602.150 2.141USD 415 1.26
2025-09-18BUY972.3202.370 2.365USD 229 1.25
2025-09-17BUY2912.2102.310 2.300USD 669 1.24
2025-09-11SELL-971.8602.000 1.986USD -193 1.23 Loss of -73 on sale
2025-09-10BUY1941.8701.980 1.969USD 382 1.23
2025-09-05SELL-971.9101.980 1.973USD -191 1.21 Loss of -74 on sale
2025-08-29SELL-2911.2801.353 1.346USD -392 1.21 Loss of -40 on sale
2025-08-27BUY1941.3601.384 1.382USD 268 1.21
2025-08-26SELL-971.3701.398 1.395USD -135 1.21 Loss of -18 on sale
2025-08-25BUY971.3901.400 1.399USD 136 1.21
2025-08-20SELL-3881.1601.220 1.214USD -471 1.21 Loss of -3 on sale
2025-08-18BUY1941.2401.250 1.249USD 242 1.20
2025-08-08SELL-1941.0601.070 1.069USD -207 1.21 Profit of 27 on sale
2025-08-05BUY971.0801.140 1.134USD 110 1.21
2025-08-01SELL-2911.1001.130 1.127USD -328 1.21 Profit of 25 on sale
2025-07-30BUY3881.1501.200 1.195USD 464 1.21
2025-07-17SELL-1941.1701.220 1.215USD -236 1.22 Profit of 0 on sale
2025-07-11SELL-7761.1601.190 1.187USD -921 1.22 Profit of 24 on sale
2025-07-07BUY2911.1401.160 1.158USD 337 1.22
2025-07-02BUY5,3351.2001.210 1.209USD 6,450 1.22
2025-06-25BUY1941.2801.319 1.315USD 255 1.22
2025-06-11BUY1941.2801.370 1.361USD 264 1.23
2025-06-10BUY1941.3401.410 1.403USD 272 1.22
2025-06-04SELL-971.2801.360 1.352USD -131 1.22 Loss of -13 on sale
2025-04-23BUY971.0801.090 1.089USD 106 1.25
2025-04-10SELL-7760.9070.980 0.973USD -755 1.29 Profit of 244 on sale
2025-04-08SELL-970.8771.020 1.006USD -98 1.30 Profit of 28 on sale
2025-04-07SELL-970.9570.976 0.974USD -94 1.30 Profit of 32 on sale
2025-04-04SELL-4850.9120.942 0.939USD -455 1.31 Profit of 180 on sale
2025-04-01BUY3880.9150.988 0.981USD 381 1.32
2025-03-31SELL-2910.9801.050 1.043USD -304 1.33 Profit of 83 on sale
2025-03-14SELL-1,5521.1101.130 1.128USD -1,751 1.38 Profit of 384 on sale
2025-03-07SELL-1941.1601.200 1.196USD -232 1.41 Profit of 41 on sale
2025-03-04SELL-971.1401.160 1.158USD -112 1.43 Profit of 26 on sale
2025-02-25BUY1941.2001.250 1.245USD 242 1.47
2025-02-19SELL-971.3501.380 1.377USD -134 1.49 Profit of 11 on sale
2025-02-13BUY2911.3001.320 1.318USD 384 1.51
2025-02-12BUY971.2801.330 1.325USD 129 1.52
2025-02-11BUY3881.2701.355 1.347USD 522 1.53
2025-01-17BUY3881.5001.580 1.572USD 610 1.55
2025-01-16BUY3881.4701.471 1.471USD 571 1.56
2025-01-10SELL-1941.5501.590 1.586USD -308 1.64 Profit of 10 on sale
2025-01-08SELL-3881.6101.725 1.714USD -665 1.69 Loss of -9 on sale
Market high and low price is on the date.

* (if shown) = market close price used not a projected price. This is used when we do not have market data available to calculate a projection

The likely trade price/value is our estimate on the likely price the trade took place at and is not the actual trade price. The likely LOSS/GAIN is our estimate. Where a profit/loss value is shown in the Likely Trade Value column, this is derived from matching trades between periods eg the most recent previous BUY is matched with the SELL for the same number of shares and the difference between the likely BUY price and likely SELL price is calculated. Where a profit or loss is shown in the Average Price of Previous Trades column, this is dervied using the likely trade price compared to the average of previous trades based on adjusted close

Shorting History of PYXS

DateShorted VolumeShort Exempt VolumeTotal Shares Traded% Shorted
2025-09-1996,200200465,81920.7%
2025-09-1891,5870371,31024.7%
2025-09-17208,6820773,91227.0%
2025-09-16170,6052,300880,51119.4%
2025-09-15100,091500408,29224.5%
2025-09-12129,7241,100405,40732.0%
2025-09-11118,8672,926319,10037.3%
2025-09-10119,9320337,62035.5%
2025-09-09141,20337,466591,91723.9%
2025-09-08410,2255,4231,256,12232.7%
2025-09-05694,5642,2961,458,86247.6%
2025-09-04238,6610614,24738.9%
2025-09-03275,6357,561703,93239.2%
2025-09-0230,00721114,30826.3%
2025-08-2924,209072,32033.5%
2025-08-2883,4177,000158,18852.7%
2025-08-2712,68520546,57927.2%
2025-08-2623,4600115,75520.3%
2025-08-25158,511291303,00652.3%
2025-08-22346,8060737,99047.0%
2025-08-21393,4724581,218,84832.3%
2025-08-2037,242095,57739.0%
2025-08-1979,15152183,89543.0%
2025-08-1872,19851154,27046.8%
2025-08-15115,0620376,82630.5%
2025-08-1493,1341,828197,22547.2%
2025-08-1375,8420192,43839.4%
2025-08-1257,204168123,50346.3%
2025-08-11304,160700557,82854.5%
2025-08-08128,75925214,82059.9%
2025-08-0758,75618082,87870.9%
2025-08-0686,926308124,34369.9%
2025-08-0552,2521,51296,52654.1%
2025-08-0455,6430103,29653.9%
2025-08-0145,4737583,43154.5%
2025-07-3151,487158108,84147.3%
2025-07-3025,43949662,48540.7%
2025-07-29131,0731,220181,85272.1%
2025-07-2822,5772,12378,97628.6%
2025-07-25116,84860,993378,24730.9%
2025-07-24309,4897,6801,613,39519.2%
2025-07-2374,8833,544136,16155.0%
2025-07-2218,76889659,24631.7%
2025-07-2122,6551,14492,68624.4%
2025-07-1832,604221122,39526.6%

The data here is derived from FINRA daily shorted trade data. The Daily Short Sale Volume is the total volume of short trades that meet certain criteria on each trade date by 6 PM ET on the trade date. The detail trade data is derived from the monthly shorted trade data which will differ in aggregate. The detail trade data is derived from the transaction level data and includes ALL trades (including exempt) and the aggregation period extends beyond 6pm.

Back to Listing

Note: All information is provided as is without warranty and should be used for indicative purposes only. You should independently check data before making any investment decision. This information is derived from third party sources and we cannot guarantee that their data is current, accurate, complete, free from defects etc and we therefore accept no responsibility for how it may be used. We accept no liability.

Copyright Market Footprint Ltd. Privacy Policy